The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
282
New hydrolyzed infant formula.
Commercially available infant formula.
Colorado Springs Health Partners
Colorado Springs, Colorado, United States
Pedia Research
Newburgh, Indiana, United States
Weight Gain
Mean weight gain (g/day) from enrollment to 4 months of age.
Time frame: 4 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pedia Research
Owensboro, Kentucky, United States
ARK-LA-Tex Pediatric Research
Bossier City, Louisiana, United States
The Clinical Trials Center
New Orleans, Louisiana, United States
Clinical Research of Nevada
Las Vegas, Nevada, United States
Institute of Clinical Research
Mayfield Heights, Ohio, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Cyn3rgy Research
Gresham, Oregon, United States
Square-1 Clinical Research
Erie, Pennsylvania, United States
...and 10 more locations